Psychobiotics and the microbiota–gut–brain axis
DOI:
https://doi.org/10.25081/imrj.2026.v16.10063Keywords:
Gut microbiota, Psychobiotics, Mental disorders, Neurodegenerative disorders, Neurodevelopmental disordersAbstract
Emerging evidence indicates that the microbiota–gut–brain axis plays a pivotal role in regulating brain function, behavior, and neurological homeostasis. Alterations in gut microbiota composition have been implicated in the pathogenesis of various mental, neurodevelopmental, and neurodegenerative disorders, leading to growing interest in psychobiotics as a promising therapeutic strategy. Psychobiotics, including probiotics, prebiotics, synbiotics, and other microbiota-targeted interventions, may exert beneficial effects by modulating gut microbial composition and activity, thereby influencing bidirectional communication along the microbiota–gut–brain axis. The beneficial effects of psychobiotics are thought to be mediated through multiple mechanisms, including regulation of the hypothalamic–pituitary–adrenal (HPA) axis, modulation of neurotransmitter synthesis, attenuation of systemic and neuroinflammation, enhancement of intestinal barrier integrity, production of microbial metabolites such as short-chain fatty acids, and interaction with the central nervous system through neural, endocrine, and immune pathways. This systematic review summarizes current evidence regarding the therapeutic potential of psychobiotics in mental disorders, including depression, anxiety, schizophrenia, and bipolar disorder, as well as neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease, and neurodevelopmental disorders including autism spectrum disorder and attention-deficit/hyperactivity disorder. In addition, the underlying biological mechanisms through which psychobiotics influence the microbiota–gut–brain axis are comprehensively discussed.
Downloads
References
Agahi, A., Hamidi, G. A., Daneshvar, R., Hamdieh, M., Soheili, M., Alinaghipour, A., Esmaeili Taba, S. M., & Salami, M. (2018). Does severity of Alzheimer's disease contribute to its responsiveness to modifying gut microbiota? A double blind clinical trial. Frontiers in Neurology, 9, 662. https://doi.org/10.3389/fneur.2018.00662
Ağagündüz, D., Kocaadam-Bozkurt, B., Bozkurt, O., Sharma, H., Esposito, R., Özoğul, F., & Capasso, R. (2022). Microbiota alteration and modulation in Alzheimer's disease by gerobiotics: the gut-health axis for a good mind. Biomedicine & Pharmacotherapy, 153, 113430. https://doi.org/10.1016/j.biopha.2022.113430
Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O.R., & Salami, M. (2016). Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: a randomized, double-blind and controlled trial. Frontiers in Aging Neuroscience, 8, 256. https://doi.org/10.3389/fnagi.2016.00256
Al-Beltagi, M. (2021). Autism medical comorbidities. World Journal of Clinical Pediatrics, 10(3), 15-28. https://doi.org/10.5409/wjcp.v10.i3.15
Andreozzi, V., Cuoco, S., Balestrieri, M., Fierro, F., Ferrara, N., Erro, R., Filippo, M. D., Barbella, G., Memoli, M. C., Silvestri, A., Squillante, M., Guglielmetti, S., Barone, P., Iovino, P., & Pellecchia, M. T. (2024). Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson’s disease: results from an open label single-arm study. Scientific Reports, 14, 23095. https://doi.org/10.1038/s41598-024-74400-w
Appleton, J. (2018). The gut-brain axis: Influence of microbiota on mood and mental health. Integrative Medicine, 17(4), 28-32.
Asad, A., Kirk, M., Zhu, S., Dong, X., & Gao, M. (2025). Effects of prebiotics and probiotics on symptoms of depression and anxiety in clinically diagnosed samples: systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews, 83(7), e1504-e1520. https://doi.org/10.1093/nutrit/nuae177
Barichella, M., Pacchetti, C., Bolliri, C., Cassani, E., Iorio, L., Pusani, C., Pinelli, G., Privitera, G., Cesari, I., Faierman, S. A., Caccialanza, R., Pezzoli, G., & Cereda, E. (2016). Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT. Neurology, 87(12), 1274-1280. https://doi.org/10.1212/WNL.0000000000003127
Barrio, C., Arias-Sánchez, S., & Martín-Monzón, I. (2022). The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: A systematic review. Psychoneuroendocrinology, 137, 105640. https://doi.org/10.1016/j.psyneuen.2021.105640
Berding, K., Bastiaanssen, T. F. S., Moloney, G. M., Boscaini, S., Strain, C. R., Anesi, A., Long-Smith, C., Mattivi, F., Stanton, C., Clarke, G., Dinan, T. G., & Cryan, J. F. (2023). Feed your microbes to deal with stress: a psychobiotic diet impacts microbial stability and perceived stress in a healthy adult population. Molecular Psychiatry, 28, 601-610. https://doi.org/10.1038/s41380-022-01817-y
Bermúdez-Humarán, L. G., Salinas, E., Ortiz, G. G., Ramirez-Jirano, L. J., Morales, J. A., & Bitzer-Quintero, O. K. (2019). From probiotics to psychobiotics: live beneficial bacteria which act on the brain-gut axis. Nutrients, 11(4), 890. https://doi.org/10.3390/nu11040890
Binda, S., Tremblay, A., Iqbal, U. H., Kassem, O., Le Barz, M., Thomas, V., Bronner, S., Perrot, T., Ismail, N., & Parker, J. (2024). Psychobiotics and the microbiota–gut–brain axis: Where do we go from here? Microorganisms, 12(4), 634. https://doi.org/10.3390/microorganisms12040634
Bonfili, L., Cecarini, V., Cuccioloni, M., Angeletti, M., Berardi, S., Scarpona, S., Rossi, G., & Eleuteri, A. M. (2018). SLAB51 probiotic formulation activates SIRT1 pathway promoting antioxidant and neuroprotective effects in an AD mouse model. Molecular Neurobiology, 55, 7987-8000. https://doi.org/10.1007/s12035-018-0973-4
Boonchooduang, N., Louthrenoo, O., Chattipakorn, N., & Chattipakorn, S .C. (2020). Possible links between gut-microbiota and attention-deficit/hyperactivity disorders in children and adolescents. European Journal of Nutrition, 59, 3391-3403. https://doi.org/10.1007/s00394-020-02383-1
Borzabadi, S., Oryan, S., Eidi, A., Aghadavod, E., Daneshvar Kakhaki, R., Tamtaji, O. R., Taghizadeh, M., & Asemi, Z. (2018). The effects of probiotic supplementation on gene expression related to ınflammation, ınsulin and lipid in patients with Parkinson's disease: A randomized, double-blind, placebocontrolled trial. Archives of Iranian Medicine, 21(7), 289-295.
Casertano, M., Fogliano, V., & Ercolini, D. (2022). Psychobiotics, gut microbiota and fermented foods can help preserving mental health. Food Research International, 152, 110892. https://doi.org/10.1016/j.foodres.2021.110892
Cheng, Y., Liu, J., & Ling, Z. (2022). Short-chain fatty acids-producing probiotics: A novel source of psychobiotics. Critical Reviews in Food Science and Nutrition, 62(28), 7929-7959. https://doi.org/10.1080/10408398.2021.1920884
Chiarotti, F., & Venerosi, A. (2020). Epidemiology of autism spectrum disorders: a review of worldwide prevalence estimates since 2014. Brain Sciences, 10(5), 274. https://doi.org/10.3390/brainsci10050274
Cocean, A.-M., & Vodnar, D. C. (2024). Exploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 134, 111073. https://doi.org/10.1016/j.pnpbp.2024.111073
Cui, J., Wang, W., Tang, Y., Feng, S., Liu, H., & Hao, Z. (2025). Application of psychobiotics in clinical treatment of mental disorders: Neurodevelopmental disorders, neurodegenerative diseases, depression and anxiety. Interdisciplinary Medicine, 3(1), e20240041. https://doi.org/10.1002/INMD.20240041
Dahiya, D., & Nigam, P. S. (2022). Clinical potential of microbial strains, used in fermentation for probiotic food, beverages and in synbiotic supplements, as psychobiotics for cognitive treatment through gut–brain signaling. Microorganisms, 10(9), 1687. https://doi.org/10.3390/microorganisms10091687
de Queiroz, S. A. L., Guimarães, D. O., Ferreira, L. A., Martinelli, L., Werly, R. M. M., Amorim, R. F., Holzbach, L. B. S. S., Badaró, R., Santos, A. A. B., Vasquez, E. C., & Silva, R. S. (2026). Kefir-derived probiotic mixture for children with autism spectrum disorder: a double-blind randomized clinical trial. BMC Pediatrics, 26, 186. https://doi.org/10.1186/s12887-026-06515-0
Del Toro-Barbosa, M., Hurtado-Romero, A., Garcia-Amezquita, L. E., & García-Cayuela, T. (2020). Psychobiotics: mechanisms of action, evaluation methods and effectiveness in applications with food products. Nutrients, 12(12), 3896. https://doi.org/10.3390/nu12123896
Dickerson, F., Adamos, M., Katsafanas, E., Khushalani, S., Origoni, A., Savage, C., Schweinfurth, L., Stallings, C., Sweeney, K., Goga, J., & Yolken, R. H. (2018). Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: a randomized controlled trial. Bipolar Disorders, 20(7), 614-621. https://doi.org/10.1111/bdi.12652
Dinan, T. G., Stanton, C., & Cryan, J. F. (2013). Psychobiotics: a novel class of psychotropic. Biological Psychiatry, 74(10), 720-726. https://doi.org/10.1016/j.biopsych.2013.05.001
Du, Y., Gao, X.-R., Peng, L., & Ge, J.-F. (2020). Crosstalk between the microbiota-gut-brain axis and depression. Heliyon, 6(6), e04097. https://doi.org/10.1016/j.heliyon.2020.e04097
Duque, A. L. R. F., Demarqui, F. M., Santoni, M. M., Zanelli, C. F., Adorno, M. A. T., Milenkovic, D., Mesa, V., & Sivieri, K. (2021). Effect of probiotic, prebiotic, and synbiotic on the gut microbiota of autistic children using an in vitro gut microbiome model. Food Research International, 149, 110657. https://doi.org/10.1016/j.foodres.2021.110657
Dziedzic, A., Maciak, K., Bli´zniewska-Kowalska, K., Gałecka, M., Kobierecka, W., & Saluk, J. (2024). The power of psychobiotics in depression: A modern approach through the microbiota–gut–brain axis: A literature review. Nutrients, 16(7), 1054. https://doi.org/10.3390/nu16071054
Elfil, M., Kamel, S., Kandil, M., Koo, B. B., & Schaefer, S. M. (2020). Implications of the gut microbiome in Parkinson's disease. Movement Disorders, 35(6), 921-933. https://doi.org/10.1002/mds.28004
Elhossiny, R. M., Elshahawy, H. H., Mohamed, H. M., & Abdelmageed, R. I. (2023). Assessment of probiotic strain Lactobacillus acidophilus LB supplementation as adjunctive management of attention-deficit hyperactivity disorder in children and adolescents: a randomized controlled clinical trial. BMC Psychiatry, 23, 823. https://doi.org/10.1186/s12888-023-05324-4
Erny, D., de Angelis, A. L. H., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., Schwierzeck, V., Utermöhlen, O., Chun, E., Garrett, W. S., McCoy, K. D., Diefenbach, A., Staeheli, P., Stecher, B., Amit, I., & Prinz, M. (2015). Host microbiota constantly control maturation and function of microglia in the CNS. Nature Neuroscience, 18, 965-977. https://doi.org/10.1038/nn.4030
Freijy, T. M., Cribb, L., Oliver, G., Metri, N.-J., Opie, R. S., Jacka, F. N., Hawrelak, J. A., Rucklidge, J. J., Ng, C. H., & Sarris, J. (2023). Effects of a high-prebiotic diet versus probiotic supplements versus synbiotics on adult mental health: The “Gut Feelings” randomised controlled trial. Frontiers in Neuroscience, 16, 1097278. https://doi.org/10.3389/fnins.2022.1097278
Fukumoto, S., Tatewaki, M., Yamada, T., Fujimiya, M., Mantyh, C., Voss, M., Eubanks, S., Harris, M., Pappas, T. N., & Takahashi, T. (2003). Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 284(5), R1269-R1276. https://doi.org/10.1152/ajpregu.00442.2002
Fülling, C., Dinan, T. G., & Cryan, J. F. (2019). Gut microbe to brain signaling: What happens in vagus. Neuron, 101(6), 998-1002. https://doi.org/10.1016/j.neuron.2019.02.008
Gao, Y., Liu, X., Pan, M., Zeng, D., Zhou, X., Tsunoda, M., Zhang, Y., Xie, X., Wang, R., Hu, W., Li, L., Yang, H., & Song, Y. (2022). Integrated untargeted fecal metabolomics and gut microbiota strategy for screening potential biomarkers associated with schizophrenia. Journal of Psychiatric Research, 156, 628-638. https://doi.org/10.1016/j.jpsychires.2022.10.072
Georgescu, D., Ancusa, O. E., Georgescu, L. A., Ionita, I., & Reisz, D. (2016). Nonmotor gastrointestinal disorders in older patients with Parkinson’s disease: is there hope?. Clinical Interventions in Aging, 11, 1601-1608. https://doi.org/10.2147/CIA.S106284
Ghaderi, A., Banafshe, H. R., Mirhosseini, N., Moradi, M., Karimi, M.-A., Mehrzad, F., Bahmani, F., & Asemi, Z. (2019). Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients. BMC Psychiatry, 19, 77. https://doi.org/10.1186/s12888-019-2059-x
Ghanaatgar, M., Taherzadeh, S., Ariyanfar, S., Razeghi Jahromi, S., Martami, F., Mahmoudi Gharaei, J., Teimourpour, A., & Shahrivar, Z. (2023). Probiotic supplement as an adjunctive therapy with Ritalin for treatment of attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled randomized clinical trial. Nutrition & Food Science, 53(1), 19-34. https://doi.org/10.1108/NFS-12-2021-0388
Góralczyk-Bińkowska, A., Szmajda-Krygier, D., & Kozłowska, E. (2022). The Microbiota–Gut–Brain Axis in Psychiatric Disorders. International Journal of Molecular Sciences, 23(19), 11245. https://doi.org/10.3390/ijms231911245
Heidarzadeh-Rad, N., Gökmen-Özel, H., Kazemi, A., Almasi, N., & Djafarian, K. (2020). Effects of a psychobiotic supplement on serum brain-derived neurotrophic factor levels in depressive patients: a post hoc analysis of a randomized clinical trial. Journal of Neurogastroenterology and Motility, 26(4), 486-495. https://doi.org/10.5056/jnm20079
Hu, F., Gao, Q., Zheng, C., Zhang, W., Yang, Z., Wang, S., Zhang, Y., & Lu, T. (2024). Encapsulated lactiplantibacillus plantarum improves Alzheimer’s symptoms in APP/PS1 mice. Journal of Nanobiotechnology, 22, 582. https://doi.org/10.1186/s12951-024-02862-1
Imran, A., Faisal, F., Noor-Ul-Huda, Jameel, A., Aslam, R., & Jabbar, I. (2025). Exploring the role of psychobiotics in mental and emotional well-being and how psychobiotics can help fight anxiety and depression. Indus Journal of Bioscience Research, 3(3), 51-56. https://doi.org/10.70749/ijbr.v3i3.823
Jamilian, H., & Ghaderi, A. (2021). The effects of probiotic and selenium co-supplementation on clinical and metabolic scales in chronic schizophrenia: A randomized, double-blind, placebo-controlled trial. Biological Trace Element Research, 199, 4430-4438. https://doi.org/10.1007/s12011-020-02572-3
Jia, L., Xiao, L., Fu, Y., Shao, Z., Jing, Z., Yuan, J., Xie, Y., Guo, J., Wang, Y., & Geng, W. (2024a). Neuroprotective effects of probiotics on anxiety-and depression-like disorders in stressed mice by modulating tryptophan metabolism and the gut microbiota. Food & Function, 15(6), 2895-2905. https://doi.org/10.1039/d3fo03897a
Jia, X., Wang, Q., Liu, M., & Ding, J. Y. (2024b). The interplay between gut microbiota and the brain-gut axis in Parkinson’s disease treatment. Frontiers in Neurology, 15, 1415463. https://doi.org/10.3389/fneur.2024.1415463
Jiménez-Pareyón, G. R., Cristóbal-Luna, J. M., García-Martínez, Y., Garfias-Noguez, C., Ramírez-Damián, M., Torres-Maravilla, E., & Sánchez-Pardo, M. E. (2025) Psychobiotics at the frontiers of neurodegenerative and neuropsychiatric research. Microorganisms, 13(12), 2718. https://doi.org/10.3390/microorganisms13122718
Kavvadia, M., Santis, G. L. D., Alwardat, N. A. A. A., Bigioni, G., Zeppieri, C., Cascapera, S., & Lorenzo, A. D. (2017). Psychobiotics as integrative therapy for neuropsychiatric disorders with special emphasis on the microbiota-gut-brain axis. Biomedicine & Prevention, 2(8), 81-88. https://doi.org/10.19252/00000006F
Kesika, P., Suganthy, N., Sivamaruthi, B. S., & Chaiyasut, C. (2021). Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer’s disease. Life Sciences, 264, 118627. https://doi.org/10.1016/j.lfs.2020.118627
Ķimse, L., Reinis, A., Miķelsone-Jansone, L., Gintere, S., & Krūmiņa, A. (2024). A narrative review of psychobiotics: probiotics that influence the gut-brain axis. Medicina, 60(4), 601. https://doi.org/10.3390/medicina60040601
Kumperscak, H. G., Gricar, A., Ülen, I., & Micetic-Turk, D. (2020). A pilot randomized control trial with the probiotic strain Lactobacillus rhamnosus GG (LGG) in ADHD: children and adolescents report better health-related quality of life. Frontiers in Psychiatry, 11, 181. https://doi.org/10.3389/fpsyt.2020.00181
Kyei-Baffour, V. O., Vijaya, A. K., Burokas, A., & Daliri, E. B.-M. (2025). Psychobiotics and the gut-brain axis: advances in metabolite quantification and their implications for mental health. Critical Rreviews in Food Science and Nutrition, 65(30), 7085-7104. https://doi.org/10.1080/10408398.2025.2459341
Lai, J., Jiang, J., Zhang, P., Xi, C., Wu, L., Gao, X., Zhang, D., Du, Y., Li, Q., Diao, X., Lu, S., Wang, Z., Song, X., & Hu, S. (2020). Gut microbial clues to bipolar disorder: State-of-the-art review of current findings and future directions. Clinical and Translational Medicine, 10(4), e146. https://doi.org/10.1002/ctm2.146
Lana, D., Traini, C., Bulli, I., Sarti, G., Magni, G., Attorre, S., Giovannini, M. G., & Vannucchi, M. G. (2024). Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer’s disease in a APP/PS1 transgenic mouse model. Frontiers in Pharmacology, 15, 1451114. https://doi.org/10.3389/fphar.2024.1451114
Lawrence, K., Fibert, P., Toribio-Mateas, M., Gregory, A. M., Hobbs, J., Quadt, F., Wright, S., Cotter, P. D., Patel, S., & Myrissa, K. (2025). Effects of kefir on symptoms, sleep, and gut microbiota in children with ADHD: a randomised controlled trial. BMC Psychiatry, 25, 1117. https://doi.org/10.1186/s12888-025-07568-8
Le Morvan de Sequeira, C., Hengstberger, C., Enck, P., & Mack, I. (2022). Effect of probiotics on psychiatric symptoms and central nervous system functions in human health and disease: A systematic review and meta-analysis. Nutrients, 14(3), 621. https://doi.org/10.3390/nu14030621
Leblhuber, F., Steiner, K., Schuetz, B., Fuchs, D., & Gostner, J. M. (2018). Probiotic supplementation in patients with Alzheimer’s dementia- an explorative intervention study. Current Alzheimer Research, 15(12), 1106-1113. https://doi.org/10.2174/1389200219666180813144834
Liang, S., Wu, X., Hu, X., Wang, T., & Jin, F. (2018). Recognizing depression from the microbiota–gut–brain axis. International Journal of Molecular Sciences, 19(6), 1592. https://doi.org/10.3390/ijms19061592
Liu, Z., Li, L., Ma, S., Ye, J., Zhang, H., Li, Y., Sair, A. T., Pan, J., Liu, X., Li, X., Yan, S., & Liu, X. (2020). High-dietary fiber intake alleviates antenatal obesity-induced postpartum depression: roles of gut microbiota and microbial metabolite short-chain fatty acid involved. Journal of Agricultural and Food Chemistry, 68(47), 13697-13710. https://doi.org/10.1021/acs.jafc.0c04290
Lu, C.-S., Chang, H.-C., Weng, Y.-H., Chen, C.-C., Kuo, Y.-S., & Tsai, Y.-C. (2021). The add-on effect of Lactobacillus plantarum PS128 in patients with Parkinson’s disease: A pilot study. Frontiers in Nutrition, 8, 650053. https://doi.org/10.3389/fnut.2021.650053
Luang-In, V., Katisart, T., Konsue, A., Nudmamud-Thanoi, S., Narbad, A., Saengha, W., Wangkahart, E., Pumriw, S., Samappito, W., & Ma, N. L. (2020). Psychobiotic effects of multi-strain probiotics originated from Thai fermented foods in a rat model. Food Science of Animal Resources, 40(6), 1014. https://doi.org/10.5851/kosfa.2020.e72
Manchia, M., Fontana, A., Panebianco, C., Paribello, P., Arzedi, C., Cossu, E., Garzilli, M., Montis, M. A., Mura, A., Pisanu, C., Congiu, D., Copetti, M., Pinna, F., Pazienza, V., Squassina, A., & Carpiniello, B. (2021). Involvement of gut microbiota in schizophrenia and treatment resistance to antipsychotics. Biomedicines, 9(8), 875. https://doi.org/10.3390/biomedicines9080875
Martínez-González, A. E., & Andreo-Martínez, P. (2023). Autism and gut microbiota: A bibliometric study. Review Journal of Autism and Developmental Disorders, 10, 630-642. https://doi.org/10.1007/s40489-022-00313-x
Merkouris, E., Mavroudi, T., Miliotas, D., Tsiptsios, D., Serdari, A., Christidi, F., Doskas, T. K., Mueller, C., & Tsamakis, K. (2024). Probiotics’ effects in the treatment of anxiety and depression: A comprehensive review of 2014–2023 clinical trials. Microorganisms, 12(2), 411. https://doi.org/10.3390/microorganisms12020411
Miao, Z., Chen, L., Zhang, Y., Zhang, J., & Zhang, H. (2024). Bifidobacterium animalis subsp. lactis Probio-M8 alleviates abnormal behavior and regulates gut microbiota in a mouse model suffering from autism. mSystems, 9(1), e0101323. https://doi.org/10.1128/msystems.01013-23
Nimgampalle, M., & Kuna, Y. (2017). Anti-Alzheimer properties of probiotic, Lactobacillus plantarum MTCC 1325 in Alzheimer’s disease induced albino rats. Journal of Clinical and Diagnostic Research, 11(8), KC01-KC05. https://doi.org/10.7860/JCDR/2017/26106.10428
Okubo, R., Koga, M., Katsumata, N., Odamaki, T., Matsuyama, S., Oka, M., Narita, H., Hashimoto, N., Kusumi, I., Xiao, J., & Matsuoka, Y. J. (2019). Effect of bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: A proof-of-concept study. Journal of Affective Disorders, 245, 377-385. https://doi.org/10.1016/j.jad.2018.11.011
O'Riordan, K. J., Collins, M. K., Moloney, G. M., Knox, E. G., Aburto, M. R., Fülling, C., Morley, S. J., Clarke, G., Schellekens, H., & Cryan, J. F. (2022). Short chain fatty acids: Microbial metabolites for gut-brain axis signalling. Molecular and Cellular Endocrinology, 546, 111572. https://doi.org/10.1016/j.mce.2022.111572
Oroojzadeh, P., Bostanabad, S. Y., & Lotfi, H. (2022). Psychobiotics: the influence of gut microbiota on the gut-brain axis in neurological disorders. Journal of Molecular Neuroscience, 72(9), 1952-1964. https://doi.org/10.1007/s12031-022-02053-3
Orsolini, L., Pompili, S., & Volpe, U. (2022). Schizophrenia: a narrative review of etiopathogenetic, diagnostic and treatment aspects. Journal of Clinical Medicine, 11(17), 5040. https://doi.org/10.3390/jcm11175040
Pärtty, A., Kalliomäki, M., Wacklin, P., Salminen, S., & Isolauri, E. (2015). A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatric Research, 77, 823-828. https://doi.org/10.1038/pr.2015.51
Phan, J., Calvo, D. C., Nair, D., Jain, S., Montagne, T., Dietsche, S., Blanchard, K., Treadwell, S., Adams, J., & Krajmalnik-Brown, R. (2024). Precision synbiotics increase gut microbiome diversity and improve gastrointestinal symptoms in a pilot open-label study for autism spectrum disorder. msystems, 9(5), e00503-24. https://doi.org/10.1128/msystems.00503-24
Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012). Acetylcholine as a Neuromodulator: Cholinergic signaling shapes nervous system function and behavior. Neuron, 76(1), 116-129. https://doi.org/10.1016/j.neuron.2012.08.036
Reininghaus, E. Z., Wetzlmair, L.-C., Fellendorf, F. T., Platzer, M., Queissner, R., Birner, A., Pilz, R., Hamm, C., Maget, A., Koidl, C., Riedrich, K., Klampfer, K., Ferk, K., & Dalkner, N. (2018). The ımpact of probiotic supplements on cognitive parameters in euthymic ındividuals with bipolar disorder: A pilot study. Neuropsychobiology, 79(1), 63-70. https://doi.org/10.1159/000492537
Reininghaus, E. Z., Wetzlmair, L.-C., Fellendorf, F. T., Platzer, M., Queissner, R., Birner, A., Pilz, R., Hamm, C., Maget, A., Rieger, A., Prettenhofer, A., Wurm, W., Mörkl, S., & Dalkner, N. (2020). Probiotic treatment in individuals with euthymic bipolar disorder: a pilot study on clinical changes and compliance. Neuropsychobiolgy, 79(1), 71-79. https://doi.org/10.1159/000493867
Rosas-Sánchez, G. U., Germán-Ponciano, L. J., Puga-Olguín, A., Soto, M. E. F., Medina, A. Y. N., Muñoz-Carillo, J. L., Rodríguez-Landa, J. F., & Soria-Fregozo, C. (2025). Gut–Brain Axis in Mood Disorders: A Narrative Review of Neurobiological Insights and Probiotic Interventions. Biomedicines, 13(8), 1831. https://doi.org/10.3390/biomedicines13081831
Ross, K. (2023). Psychobiotics: Are they the future intervention for managing depression and anxiety? A literature review. Explore, 19(5), 669-680. https://doi.org/10.1016/j.explore.2023.02.007
Sabouri, S., Esmailzadeh, M., Sadeghinejad, A., Shahrbabaki, M. E., Asadikaram, G., & Nikvarz, N. (2022). The effect of adjunctive probiotics on markers of inflammation and oxidative stress in bipolar disorder: a double-blind, randomized, controlled trial. Journal of Psychiatric Practice, 28(5), 373-382. https://doi.org/10.1097/PRA.0000000000000660
Sarkar, A., Lehto, S. M., Harty, S., Dinan, T. G., Cryan, J. F., & Burnet, P. W. J. (2016). Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends Neurosciences, 39(11), 763-781. https://doi.org/10.1016/j.tins.2016.09.002
Schaub, A.-C., Schneider, E., Vazquez-Castellanos, J. F., Schweinfurth, N., Kettelhack, C., Doll, J. P. K., Yamanbaeva, G., Mählmann, L., Brand, S., Beglinger, C., Borgwardt, S., Raes, J., Schmidt, A., & Lang, U. E. (2022). Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial. Translational Psychiatry, 12, 227. https://doi.org/10.1038/s41398-022-01977-z
Schmitt, L. M., Smith, E. G., Pedapati, E. V., Horn, P. S., Will, M., Lamy, M., Barber, L., Trebley, J., Meyer, K., Heiman, M., West, K. H. J., Hughes, P., Ahuja, S., & Erickson, C. A. (2023). Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder. Scientific Reports, 13, 5192. https://doi.org/10.1038/s41598-023-30909-0
Shaaban, S. Y., El Gendy, Y. G., Mehanna, N. S., El-Senousy, W. M., El-Feki, H. S. A., Saad, K., & El-Asheer, O. M. (2018). The role of probiotics in children with autism spectrum disorder: A prospective, open-label study. Nutritional Neuroscience, 21(9), 676-681. https://doi.org/10.1080/1028415X.2017.1347746
Skott, E., Yang, L. L., Stiernborg, M., Söderström, Å., Rȕegg, J., Schalling, M., Forsell, Y., Giacobini, M., & Lavebratt, C. (2020). Effects of a synbiotic on symptoms, and daily functioning in attention deficit hyperactivity disorder–a double-blind randomized controlled trial. Brain, Behavior, and Immunity, 89, 9-19. https://doi.org/10.1016/j.bbi.2020.05.056
Skowron, K., Budzyńska, A., Wiktorczyk-Kapischke, N., Chomacka, K., Grudlewska-Buda, K., Wilk, M., Wałecka-Zacharska, E., Andrzejewska, M., & Gospodarek Komkowska, E. (2022). The Role of Psychobiotics in Supporting the Treatment of Disturbances in the Functioning of the Nervous System—A Systematic Review. International Journal of Molecular Sciences, 23(14), 7820. https://doi.org/10.3390/ijms23147820
Smith, K. S., Greene, M. W., Babu, J. R., & Frugé, A. D. (2021). Psychobiotics as treatment for anxiety, depression, and related symptoms: a systematic review. Nutritional Neuroscience, 24(12), 963-977. https://doi.org/10.1080/1028415X.2019.1701220
Soleimani, R., Jalali, M. M., Bakhtiari, H., Eslamdoust-Siahestalkhi, F., & Jalali, S.M. (2023). Probiotic add-on therapy in the first-episode schizophrenia: A randomized controlled trial. Caspian Journal of Neurological Sciences, 9(4), 229-243. https://doi.org/10.32598/CJNS.9.35.228.2
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X.-N., Kubo, C., & Koga, Y. (2004). Postnatal microbial colonization programs the hypothalamic—pituitary—adrenal system for stress response in mice. The Journal of Physiology, 558(1), 263-275. https://doi.org/10.1113/jphysiol.2004.063388
Sun, J., Li, H., Jin, Y., Yu, J., Mao, S., Su, K.-P., & Liu, J. (2021). Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson’s disease via gut microbiota-GLP-1 pathway. Brain, Behavior, and Immunity, 91, 703-715. https://doi.org/10.1016/j.bbi.2020.10.014
Tan, A. H., Hor, J. W., Chong, C. W., & Lim, S.-Y. (2020). Probiotics for Parkinson’s disease: current evidence and future directions. JGH Open, 5(4), 414-419. https://doi.org/10.1002/jgh3.12450
Tarr, A. J., Galley, J. D., Fisher, S. E., Chichlowski, M., Berg, B. M., & Bailey, M. T. (2015). The prebiotics 3′ Sialyllactose and 6′ Sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: Evidence for effects on the gut–brain axis. Brain, Behavior, and Immunity, 50, 166-177. https://doi.org/10.1016/j.bbi.2015.06.025
Tian, P., O'Riordan, K. J., Lee, Y.-K., Wang, G., Zhao, J., Zhang, H., Cryan, J. F., & Chen, W. (2020). Towards a psychobiotic therapy for depression: Bifidobacterium breve CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice. Neurobiology of Stress, 12, 100216. https://doi.org/10.1016/j.ynstr.2020.100216
Tian, P., Zou, R., Wang, L., Chen, Y., Qian, X., Zhao, J., Zhang, H., Qian, L., Wang, Q., Wang, G., & Chen, W. (2023). Multi-probiotics ameliorate major depressive disorder and accompanying gastrointestinal syndromes via serotonergic system regulation. Journal of Advanced Research, 45, 117-125. https://doi.org/10.1016/j.jare.2022.05.003
Tomasik, J., Yolken, R. H., Bahn, S., & Dickerson, F. B. (2015). Immunomodulatory effects of probiotic supplementation in schizophrenia patients: a randomized, placebo-controlled trial. Biomarker Insights, 10, 47-54. https://doi.org/10.4137/Bmi.s22007
Tremblay, A., Lingrand, L., Maillard, M., Feuz, B., & Tompkins, T. A. (2021). The effects of psychobiotics on the microbiota-gut-brain axis in early-life stress and neuropsychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 105, 110142. https://doi.org/10.1016/j.pnpbp.2020.110142
Wang, H., He, S., Xin, J., Zhang, T., Sun, N., Li, L., Ni, X., Zeng, D., Ma, H., & Bai, Y. (2021). Psychoactive effects of Lactobacillus johnsonii against restraint stress-ınduced memory dysfunction in mice through modulating ıntestinal ınflammation and permeability-a study based on the gut-brain axis hypothesis. Frontiers in Pharmacology, 12, 662148. https://doi.org/10.3389/fphar.2021.662148
Wang, L.-J., Tsai, C.-S., Chou, W.-J., Kuo, H.-C., Huang, Y.-H., Lee, S.-Y., Dai, H.-Y., Yang, C.-Y., Li, C.-J., & Yeh, Y.-T. (2024). Add-on Bifidobacterium bifidum supplement in children with attention-deficit/hyperactivity disorder: a 12-week randomized double-blind placebo-controlled clinical trial. Nutrients, 16(14), 2260. https://doi.org/10.3390/nu16142260
Wang, L.-J., Yang, C.-Y., Kuo, H.-C., Chou, W.-J., Tsai, C.-S., & Lee, S.-Y. (2022). Effect of Bifidobacterium bifidum on clinical characteristics and gut microbiota in attention-deficit/hyperactivity disorder. Journal of Personalized Medicine, 12(2), 227. https://doi.org/10.3390/jpm12020227
Wang, Y., Li, N., Yang, J.-J., Zhao, D.-M., Chen, B., Zhang, G.-Q., Chen, S., Cao, R.-F., Yu, H., Zhao, C.-Y., Zhao, L., Ge, Y.-S., Liu, Y., Zhang, L.-H., Hu, W., Zhang, L., & Gai, Z.-T. (2020). Probiotics and fructo-oligosaccharide intervention modulate the microbiota-gut brain axis to improve autism spectrum reducing also the hyper-serotonergic state and the dopamine metabolism disorder. Pharmacological Research, 157, 104784. https://doi.org/10.1016/j.phrs.2020.104784
WHO. (2022). World mental health report: transforming mental health for all. World Health Organization. Retrieved from https://iris.who.int/server/api/core/bitstreams/40e5a13a-fe50-4efa-b56d-6e8cf00d5bfa/content
WHO. (2025). World mental health today: latest data. World Health Organization. Retrieved from https://iris.who.int/server/api/core/bitstreams/31714489-1345-4439-8b37-6cbdc52e15ca/content
Williams-Gray, C. H., & Worth, P. F. (2023). Parkinson's disease and related conditions. Medicine, 51(9), 645-651. https://doi.org/10.1016/j.mpmed.2023.06.004
Wu, H., Denna, T. H., Storkersen, J. N., & Gerriets, V. A. (2019). Beyond a neurotransmitter: The role of serotonin in inflammation and immunity. Pharmacological Research, 140, 100-114. https://doi.org/10.1016/j.phrs.2018.06.015
Xiao-hang, Q., Si-yue, C., & Hui-dong, T. (2024). Multi-strain probiotics ameliorate Alzheimer’s-like cognitive impairment and pathological changes through the AKT/GSK-3β pathway in senescence-accelerated mouse prone 8 mice. Brain, Behavior, and Immunity, 119, 14-27. https://doi.org/10.1016/j.bbi.2024.03.031
Xiong, R.-G., Li, J., Cheng, J., Zhou, D.-D., Wu, S.-X., Huang, S.-Y., Saimaiti, A., Yang, Z.-J., Gan, R.-Y., & Li, H.-B. (2023). The role of gut microbiota in anxiety, depression, and other mental disorders as well as the protective effects of dietary components. Nutrients, 15, 3258. https://doi.org/10.3390/nu15143258
Yang, L. L., Stiernborg, M., Skott, E., Xu, J., Wu, Y., Landberg, R., Arefin, S., Kublickiene, K., Millischer, V., Nilsson, I. A. K., Schalling, M., Giacobini, M., & Lavebratt, C. (2023). Effects of a synbiotic on plasma immune activity markers and short-chain fatty acids in children and adults with ADHD-A randomized controlled trial. Nutrients, 15(5), 1293. https://doi.org/10.3390/nu15051293
Zandifar, A., Badrfam, R., Mohammaditabar, M., Kargar, B., Goodarzi, S., Hajialigol, A., Ketabforoush, S., Heidari, A., Fathi, H., Shafiee, A., & Pourjafar, H. (2025). The effect of prebiotics and probiotics on levels of depression, anxiety, and cognitive function: A meta‐analysis of randomized clinical trials. Brain and Behavior, 15(3), e70401. https://doi.org/10.1002/brb3.70401
Zhang, Q., Chen, B., Zhang, J., Dong, J., Ma, J., Zhang, Y., Jin, K., & Lu, J. (2023). Effect of prebiotics, probiotics, synbiotics on depression: Results from a meta-analysis. BMC Psychiatry, 23, 477. https://doi.org/10.1186/s12888-023-04963-x
Zhu, G., Zhao, J., Zhang, H., Chen, W., & Wang, G. (2021). Probiotics for mild cognitive ımpairment and Alzheimer’s disease: A systematic review and meta-analysis. Foods, 10(7), 1672. https://doi.org/10.3390/foods10071672
Zhu, R., Fang, Y., Li, H., Liu, Y., Wei, J., Zhang, S., Wang, L., Fan, R., Wang, L., Li, S., & Chen, T. (2023). Psychobiotic Lactobacillus plantarum JYLP-326 relieves anxiety, depression, and insomnia symptoms in test anxious college via modulating the gut microbiota and its metabolism. Frontiers in Immunology, 14, 1158137. https://doi.org/10.3389/fimmu.2023.1158137
Published
How to Cite
Issue
Section
Copyright (c) 2026 Seda Seyirt, Pınar Şanlıbaba
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
.